Blockchain Registration Transaction Record

Quantum BioPharma CEO Talks Lucid-MS and unbuzzd on Podcast

Quantum BioPharma (QNTM) executive Anthony Durkacz discusses Lucid-MS and unbuzzd in BioMedWire Podcast, revealing strategy for multiple sclerosis drug and alcohol metabolism accelerator.

Quantum BioPharma CEO Talks Lucid-MS and unbuzzd on Podcast

This news matters because it provides investors and the public with direct insight into Quantum BioPharma's strategy for two key products: Lucid-MS for multiple sclerosis and unbuzzd for alcohol metabolism. Understanding the company's approach helps stakeholders evaluate its potential for growth and impact in the biotech sector. The executive's transparency on a podcast underscores the importance of thought leadership in demystifying complex medical innovations and building investor confidence.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x3d952dd686f4c1b290254441e395ec5734ea0d6a6a14858587787bf0e4e3617d
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprinttint639m-ea6c14139729d440b5a77141aa6d7354